Genetic progression model for head and neck cancer: implications for field cancerization.
about
FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformationUpregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakiaOral Leukoplakia as It Relates to HPV Infection: A ReviewNSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaEvolution of neoplastic cell lineages in Barrett oesophagusGenetic alteration and gene expression modulation during cancer progressionM6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosisThe etiologic spectrum of head and neck squamous cell carcinoma in young patientsBiomarkers of head and neck cancer, tools or a gordian knot?Lessons learned from next-generation sequencing in head and neck cancerAn updated overview of HPV-associated head and neck carcinomasOral premalignancy: the roles of early detection and chemopreventionEarly detection and personalized treatment in oral cancer: the impact of omics approachesToward the use of precision medicine for the treatment of head and neck squamous cell carcinomaMolecular Aspects of Head and Neck Cancer TherapyIndependent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomasDifferential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neckGenetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screeningGenome stability pathways in head and neck cancersComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsMolecular changes in the multistage pathogenesis of head and neck cancerOtolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014)Novel insight into mutational landscape of head and neck squamous cell carcinomaRegulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicComparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinomaMoving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes.Analysis of loss of heterozygosity in Korean patients with keratoacanthoma.Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 2.Tumor heterogeneity: causes and consequencesRETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancersSingle nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumorsA dynamic oral cancer field: unraveling the underlying biology and its clinical implication.Causes of death in long-term survivors of head and neck cancer.The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study.Molecular pathogenesis of oral squamous carcinoma.
P2860
Q21092133-12319F39-33C0-479E-B4B4-5DF31210B199Q21134532-F527A3C2-ABAA-4D03-A7AE-8159D2CF0C4DQ21285037-DA830E5D-DA03-40E0-8855-0A5F21E6A126Q21563424-EC9EC99A-7477-4825-A1F8-29B7F43A772FQ24676889-FE2A0352-39F2-4CBE-884F-DFB351392363Q24798750-9FB0EF26-1F0B-46F3-B84A-76492D3B39AFQ24805128-D73DD281-961D-41B9-BB46-4357A7BF0C30Q26741362-91057097-B8E1-450A-B0E4-37A734FC9B57Q26784289-C289464C-E78E-4304-9E9A-860424F9BF41Q27009209-6DA115BA-BB38-4B21-B29B-DCF7B7E9247CQ27014019-F6D5229F-0D2F-44DC-AE63-6FBE987EA6AEQ27693327-C0B74998-EEA2-45A7-97FE-5AE6A4A01ED9Q28073927-AE60CE68-1B29-4489-AA16-DF92132410D5Q28074691-B76615EB-4F8A-415B-9B8F-4B957E2AF42FQ28082815-9D1E828D-C24D-4DB7-B91F-23790C408D5FQ28277102-A84E2232-E9FB-4065-98DD-9D8C4B93BB5CQ28346765-818CADCA-1240-4AAB-A933-7CD61E022C67Q28363010-082A2274-1718-437C-806A-A91CA64C33C0Q28391355-051264DC-6257-4F05-BFA6-77C47EE82CF5Q28485279-CE9A97B4-9E12-461F-857B-73F91137A0B9Q28728638-29F9D506-C55D-4A05-A934-908FEFCF252EQ30361906-DB3ED004-1AAA-43E6-904D-2FC67DD1424CQ30441193-6A22D15C-C684-46AD-B5C6-66E63E569830Q30498812-5820FDB3-4631-4750-8EC7-E283060D2898Q30528676-8B5319CA-F8A6-4577-877F-0422F098FECAQ31043365-87F90FE1-0AE6-44F7-9DD7-DBD9CC69C4B9Q33298692-8030E6EA-60FA-4E99-A1F5-C8180FCC60E8Q33599616-79D7FC78-9DB7-4B61-BF37-A042A29980E0Q33610394-5B8703BB-D15E-4BB2-8836-E90470C0C12BQ33611479-D72AF999-9669-4A8E-8846-73CAB800399EQ33624298-5D9FC3E5-7E72-4F45-96F0-0CC10B36C9E5Q33723572-8182C631-8250-4C4F-ADE6-FD93D8EFBF3DQ33822845-2E28BDC8-F1F0-4CE7-B41A-A79DCD4ACC27Q33898355-99B6FD7D-1191-4433-B78C-377446B9F603Q33902184-B6B8975A-B985-4169-AC57-8685000D45B0Q33905652-227031A4-9D5F-4D55-91F5-3C96FCDD295BQ33911094-F59CF231-4954-410A-A0E2-EBCE7AF67CFFQ33913896-AC64EA4D-5782-4EF1-96E6-95A76FF1DA8BQ33918472-5B2EDEB1-6C9E-4C8E-A8A4-0ADBC8148561Q33918555-42CDD741-7E7F-4735-96A6-4302F4FD6890
P2860
Genetic progression model for head and neck cancer: implications for field cancerization.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Genetic progression model for head and neck cancer: implications for field cancerization.
@ast
Genetic progression model for head and neck cancer: implications for field cancerization.
@en
Genetic progression model for head and neck cancer: implications for field cancerization.
@nl
type
label
Genetic progression model for head and neck cancer: implications for field cancerization.
@ast
Genetic progression model for head and neck cancer: implications for field cancerization.
@en
Genetic progression model for head and neck cancer: implications for field cancerization.
@nl
prefLabel
Genetic progression model for head and neck cancer: implications for field cancerization.
@ast
Genetic progression model for head and neck cancer: implications for field cancerization.
@en
Genetic progression model for head and neck cancer: implications for field cancerization.
@nl
P2093
P1433
P1476
Genetic progression model for head and neck cancer: implications for field cancerization.
@en
P2093
Califano J
Greenberg B
Piantadosi S
Sidransky D
P304
P407
P577
1996-06-01T00:00:00Z